Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cash Flows from Operating Activities:
Net Income (loss)	$ (165,534)	$ 8,791
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	242	246
Loss on extinguishment of debt	0	0
(Gain)/Loss from change in fair value of hybrid financial instruments	31,170	(2,471)
(Gain)/Loss from change in fair value of derivative liability - warrants	41,488	(1,782)
(Gain)/Loss from change in fair value of derivative liability - Series C and D preferred stock and debentures	89,649	(6,671)
Interest expense related to convertible debt	2,392	753
Interest paid on convertible debt	0	(1,000)
Stock-based compensation expense	7	27
Increase in value of life insurance policies	34	(21)
Changes in operating assets and liabilities
Trade and other accounts receivable	(300)	46
Inventories	0	(6)
Prepaid expenses and other assets	(72)	17
Accounts payable and accrued liabilities	17	(200)
Deferred revenue and other current liabilities	(59)	781
Net cash used in operating activities	(966)	(1,490)
Cash Flows from Investing Activities:
Acquisition of property and equipment	(3)	(4)
Net cash used in investing activities	(3)	(4)
Cash Flows from Financing Activities:
Borrowings under convertible debt instruments, net	1,225	1,460
Net cash provided by financing activities	1,225	1,460
Effect of exchange rate changes on cash	8	3
Net change in cash and cash equivalents	264	(31)
Cash and cash equivalents, beginning of period	30	80
Cash and cash equivalents, end of period	294	49
Supplemental cash flow information:
Interest paid during the period	0	1,001
Series C preferred stock converted to common stock	878	970
Series D preferred stock converted to common stock	776	0
Convertible Debentures converted to common stock	5,530	0
Shares issued for acquisition of patent rights	$ 0	$ 350